104 related articles for article (PubMed ID: 27616053)
1. IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10.
Chen L; Al-Kzayer LF; Liu T; Kobayashi N; Nakazawa Y; Koike K
Pediatr Blood Cancer; 2017 Feb; 64(2):311-314. PubMed ID: 27616053
[TBL] [Abstract][Full Text] [Related]
2. Double-hit lymphoma demonstrating t(6;14;18)(p25;q32;q21), suggesting two independent dual-hit translocations, MYC/BCL-2 and IRF4/BCL-2.
Tabata R; Yasumizu R; Tabata C; Kojima M
J Clin Exp Hematop; 2013; 53(2):141-50. PubMed ID: 23995111
[TBL] [Abstract][Full Text] [Related]
3. BCL6, MUM1, and CD10 expression in mantle cell lymphoma.
Gualco G; Weiss LM; Harrington WJ; Bacchi CE
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):103-8. PubMed ID: 19826251
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation of immunohistochemical profiles in diffuse large B-cell lymphoma: a Chinese study.
Chen Z; Du Z; Chen J; Chen Z; Bao Y; Tang F
Med Oncol; 2011 Mar; 28(1):241-8. PubMed ID: 20165991
[TBL] [Abstract][Full Text] [Related]
5. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G
Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451
[TBL] [Abstract][Full Text] [Related]
6. CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.
Cozzolino I; Varone V; Picardi M; Baldi C; Memoli D; Ciancia G; Selleri C; De Rosa G; Vetrani A; Zeppa P
Cancer Cytopathol; 2016 Feb; 124(2):135-43. PubMed ID: 26414904
[TBL] [Abstract][Full Text] [Related]
7. B-cell lymphomas with coexpression of CD5 and CD10.
Dong HY; Gorczyca W; Liu Z; Tsang P; Wu CD; Cohen P; Weisberger J
Am J Clin Pathol; 2003 Feb; 119(2):218-30. PubMed ID: 12579992
[TBL] [Abstract][Full Text] [Related]
8. IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1).
Tinguely M; Thies S; Frigerio S; Reineke T; Korol D; Zimmermann DR
Leuk Lymphoma; 2014 Jan; 55(1):136-42. PubMed ID: 23573829
[TBL] [Abstract][Full Text] [Related]
9. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.
Karube K; Guo Y; Suzumiya J; Sugita Y; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Takeshita M; Kikuchi M; Nakamura N; Takasu O; Arakawa F; Tagawa H; Seto M; Ohshima K
Blood; 2007 Apr; 109(7):3076-9. PubMed ID: 17138820
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and prognostic analysis of Waldeyer ring B-cell lymphoma.
Ma Z; Shi Y; Pang X; Li X; Cui W; Zhang W
Medicine (Baltimore); 2020 Jan; 99(2):e18670. PubMed ID: 31914056
[TBL] [Abstract][Full Text] [Related]
11. Low-grade B-cell lymphoma with coexpression of both CD5 and CD10. A report of 3 cases.
Barekman CL; Aguilera NS; Abbondanzo SL
Arch Pathol Lab Med; 2001 Jul; 125(7):951-3. PubMed ID: 11419985
[TBL] [Abstract][Full Text] [Related]
12. MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes.
Naresh KN
Haematologica; 2007 Feb; 92(2):267-8. PubMed ID: 17296585
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Expression of CD10, BCL6 and MUM1 in Differentiating Diffuse Large B Cell Lymphoma Subtypes.
Bajwa AA; Khadim MT; Din HU; Ali SS; Jamil U; Khan UAS
J Coll Physicians Surg Pak; 2017 Oct; 27(10):621-624. PubMed ID: 29056123
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma.
Kreher S; Jöhrens K; Strehlow F; Martus P; Borowiec K; Radke J; Heppner F; Roth P; Thiel E; Pietsch T; Weller M; Korfel A
Neuro Oncol; 2015 Jul; 17(7):1016-21. PubMed ID: 25817328
[TBL] [Abstract][Full Text] [Related]
15. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
Ye ZY; Cao YB; Lin TY; Lin HL
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):654-9. PubMed ID: 18194597
[TBL] [Abstract][Full Text] [Related]
16. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes.
Harada S; Suzuki R; Uehira K; Yatabe Y; Kagami Y; Ogura M; Suzuki H; Oyama A; Kodera Y; Ueda R; Morishima Y; Nakamura S; Seto M
Leukemia; 1999 Sep; 13(9):1441-7. PubMed ID: 10482997
[TBL] [Abstract][Full Text] [Related]
17. CD5-positive follicular lymphoma characterized by CD25, MUM1, low frequency of t(14;18) and poor prognosis.
Miyoshi H; Sato K; Yoshida M; Kimura Y; Kiyasu J; Ichikawa A; Ishibashi Y; Arakawa F; Nakamura Y; Nakashima S; Niino D; Sugita Y; Ohshima K
Pathol Int; 2014 Mar; 64(3):95-103. PubMed ID: 24698419
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
van Imhoff GW; Boerma EJ; van der Holt B; Schuuring E; Verdonck LF; Kluin-Nelemans HC; Kluin PM
J Clin Oncol; 2006 Sep; 24(25):4135-42. PubMed ID: 16943530
[TBL] [Abstract][Full Text] [Related]
19. Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup.
Petit B; Chaury MP; Le Clorennec C; Jaccard A; Gachard N; Moalic-Judge S; Labrousse F; Cogné M; Bordessoule D; Feuillard J
Haematologica; 2005 Feb; 90(2):200-6. PubMed ID: 15710572
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
